Clinical Trials on Erythromelalgia

Total 9 results

Xenon Pharmaceuticals Inc.

Completed

Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)

Inherited Erythromelalgia | Primary Erythromelalgia

Netherlands
Xenon Pharmaceuticals Inc.

Completed

Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia

Inherited Erythromelalgia | Primary Erythromelalgia

United States
Pfizer

Completed

Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia (IEM)

Inherited Erythromelalgia

United States
Biogen

Completed

A Phase 2a Study of BIIB074 in the Treatment of Erythromelalgia

Primary Inherited Erythromelalgia

United States
VA Connecticut Healthcare System

Completed

Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations

Erythromelalgia

United States
Groupe Hospitalier Paris Saint Joseph

Completed

Vascular and Neurologic Exploration of Small Nervous Fiber by Sudoscanner and QST

Erythermalgia

France
AlgoTherapeutix

Recruiting

EASE (Efficacy of ATX01 Study in Erythromelalgia) (EASE)

Erythromelalgia

United States, Germany
St. Olavs Hospital
Norwegian University of Science and Technology

Recruiting

Spinal Cord Stimulation for Refractory Pain in Erythromelalgia

Erythromelalgia

Norway
King's College London
University of Oxford; Neuroscience Technologies S.L.P

Unknown

Painful Channelopathies Study (PCS)

Chronic Pain | Hereditary Sensory and Autonomic Neuropathies | Erythromelalgia | Pain Insensitivity, Congenital

United Kingdom

Clinical Trials on Erythromelalgia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations